Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn ( CYDY ), commented, “We are very pleased with the MHRA’s decision to clear our BLA for filing and our team is finalizing the remaining details to ensure a complete filing very soon. We hope to receive notice of acceptance within two weeks of our filing.